Relapsed refractory refers to a research area focused on studying diseases or conditions that have relapsed or become resistant to previous treatments. This could include cancers, autoimmune diseases, or infections that have returned or stopped responding to standard therapies. Researchers in this area work to understand the mechanisms behind relapse and resistance, and develop new treatment strategies to overcome these challenges. By studying relapsed refractory conditions, scientists aim to improve patient outcomes and quality of life.